Scientists Lock Doors for Mysterious Closed-Door Meetings
Published Date: 12/4/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on January 8-9, 2026, to review important grant applications for biomedical research projects. These meetings are private to protect sensitive information and personal privacy. Scientists and research centers applying for funding are affected, with no direct money changes announced but key decisions on grants will be made.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Key Grant Decisions Will Be Made
The Center for Scientific Review will review and evaluate grant applications for the COBRE Phase 2 and INBRE programs during the January 8-9, 2026 virtual meeting, and key decisions on those grants will be made. The notice states there are no direct money changes announced in the notice itself.
Grant Reviews Held Closed to Public
The National Institutes of Health is holding a closed virtual meeting on January 8-9, 2026 (10:00 a.m. to 6:00 p.m.) to review grant applications. The meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of applicants.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-21908 — CME Securities Clearing, Inc.; Order Granting an Application for Registration as a Clearing Agency Under Section 17A of the Securities Exchange Act of 1934
The SEC has officially approved CME Securities Clearing, Inc. to act as a clearing agency for U.S. Treasury securities, meaning they’ll help make these big money trades safer and smoother. This change affects banks, traders, and anyone dealing with U.S. Treasury transactions by adding a new trusted middleman. The approval process wrapped up in late 2025, setting the stage for CMESC to start operations soon without any immediate cost changes for users.
Next: 2025-21913 — Proposed Collection; 60-Day Comment Request; Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH wants to learn how clinical research training helps healthcare pros in schools and labs do their jobs better. They’re asking for your thoughts on a new survey that will collect this info, making sure it’s useful and not too much work. You’ve got 60 days to share your ideas before they move forward—no big costs, just a chance to improve training for the future!